Quantcast

UC Davis Health System

Nancy E. Lane, M.D.

Nancy E. Lane

Clinical/Research Interests

Nancy Lane is a nationally recognized expert in the medical management of osteoporosis. She is a consultant reviewer for numerous peer-reviewed journals, among them JAMA, Journal of Bone and Mineral Research, Annals of Internal Medicine, and Journal of Bone and Joint Surgery. Nancy Lane is a fully funded NIH researcher on osteoporosis and bone health. One special area of expertise is the use of PTH for the treatment of glucocorticoid-induced osteoporosis and the genetics epidemiology of hip OA in elderly women and men.

Title:

Professor
Director, UC Davis Center for Healthy Aging

Specialty:

Internal Medicine

Education:

UC San Francisco School of Medicine
San Francisco, California
M.D. 1980

UC Davis
Davis, California
B.S. 1976

Residency:

Mount Zion Hospital and Medical Center
San Francisco, California
1980-83

Fellowships:

Palo Alto Veterans Adminstration Hospital and Stanford University Medical Center
Stanford, California
1983-85
Rheumatology

Board Certifications:

American Board of Internal Medicine, Rheumatology, 1986
American Board of Internal Medicine, 1983

Select Recent Publications:

Lane NE, Yao W, Ross P, Sheppard D. b5 Integrin deficiency Increases Osteoclast Generation and Activity and Induces Greater Bone Loss Following Ovariectomy. J Bone Miner Res 20(1):58-66, 2005.

Kinney JH, Stolken JS, Smith TS, Ryaby JT, Lane NE. An orientation distribution function for trabecular bone. Bone. 2005 Feb;36(2):193-201.

Offley SC, Guo TZ,, Tzuping, W, Clark JD, Vogel H, Lindsey DP, Jacobs CR, Lane NE, Kingery WS. Capsaicin sensitive sensory neurons contribute to the maintenance of cancellous bone mass, structure, and strength. J Bone Miner Res 20(2):257-267, 2005.

Beattie MS, Lane NE, Nevitt MC, Hung YY. Association of statin use and development and progression of hip osteoarthritis in elderly women. Journal of Rheumatology 32(1): 106-110, 2005.

Lian K, Lang T, Keyak J, Lane NE. The comparison of hip QCT measurements of trabecular and cortical bone and bone strength assessments by finite element modeling in glucocorticoid-induced osteoporotic postmenopausal women and postmenopausal women as controls. Osteoporosis International Sep 28, 2004.

Humphrey MB, Ogasawara K, Yao W, Spusta SC, Daws MR, Lane NE, Lanier LL, Nakamura mc. The signaling adapter protein DAP-12 regulates multinucleation during osteoclast development. J Bone Miner Res 19 (2): 224-234, 2004.

Buxton E, Yao W, Lane NE Changes in serum RANKL, OPG and IL-6 levels in glucocorticoid-induced osteoporosis, JCEM, 2004 Jul;89(7):3332-6.

Menkes CJ, Lane NE. Are osteophytes good or bad? Osteoarthritis and Cartilage 12, S53-54, 2004.

Goemaere S, Liberman U, Adachi J, Hawkins F, Lane N, Saag K, Schnitzer T, Kaufman J, Malice MP, Carofano W, Daifotis A. Non-vertebral fracture, time on treatment and bone mineral density in glucocorticoid-treated patients: a retrospective study Journal of Clinical Rheumatology 9(3):170-175, 2003.

Lane NE, Williams EN, Hung YY, Hochberg MC, Cummings SR, Nevitt MC. Association of nitrate use with risk of new radiographic features of hip OA in elderly while women. Arthritis and Rheumatism 49(6): 752-758, 2003.

To see if Nancy E. Lane is accepting new patients, or for assistance finding a UC Davis doctor, please call (800) 2-UC DAVIS.